GSTM1 and cancer: Based on research related to Hb and RDW in malignant tumors, Sun et al. 24 was the first to report the prognostic value of the baseline Hb‐to‐RDW ratio (HRR) in esophageal squamous cell carcinoma (ESCC) in 2016.